— Know what they know.
Not Investment Advice

HO1.DE XETRA

Hologic Inc
1W: -5.9% 1M: -8.2% 3M: -23.3% 1Y: -19.4% 3Y: -18.3% 5Y: +84.2%
€61.50
Last traded 2025-03-14 — delisted
XETRA · Healthcare · Medical - Equipment & Services
Smart Money Score
No convergence signal
Key Statistics
Market Cap€0.0M ($0.0M)
52W Range60.5-77
Volume0
Avg Volume33
Beta1.41
Dividend
Analyst Ratings
2 Buy 8 Hold 0 Sell
Consensus Hold
Company Info
CEOStephen MacMillan
Employees6,478
SectorHealthcare
IndustryMedical - Equipment & Services
IPO Date1990-03-01
250 Campus Dr
Marlborough, MA
US
15082632900
About Hologic Inc

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. The company is headquartered in Marlborough, Massachusetts and currently employs 6,478 full-time employees. The firm operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. The company offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1). The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems. The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms